Zacks Investment Research upgraded shares of Aemetis (NASDAQ:AMTX) from a sell rating to a hold rating in a report issued on Monday morning.

According to Zacks, “Aemetis, Inc. is an advanced fuels and renewable chemicals company. It produces renewable chemicals and fuels using patented microbes and processes. Aemetis owns and operates an ethanol animal feed plant in California to produce D5 Advanced Biofuels using the sorghum/biogas/CHP pathway. The Company also built, owns, and operates a renewable chemicals and advanced fuels production facility on the East Coast of India producing high quality, distilled biodiesel and refined glycerin for customers in Europe and Asia. Aemetis, Inc. is headquartered in Cupertino, California. “

Separately, B. Riley reaffirmed a neutral rating on shares of Aemetis in a research report on Wednesday, November 1st.

Shares of Aemetis (NASDAQ AMTX) traded down $0.02 during midday trading on Monday, hitting $0.70. The stock had a trading volume of 14,700 shares, compared to its average volume of 44,482. Aemetis has a 1 year low of $0.51 and a 1 year high of $2.50. The company has a debt-to-equity ratio of -1.87, a current ratio of 0.37 and a quick ratio of 0.20. The stock has a market cap of $14.27, a PE ratio of -0.69 and a beta of 0.69.

A hedge fund recently bought a new stake in Aemetis stock. Ninepoint Partners LP purchased a new stake in shares of Aemetis Inc (NASDAQ:AMTX) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 1,151,373 shares of the specialty chemicals company’s stock, valued at approximately $1,002,000. Ninepoint Partners LP owned about 5.81% of Aemetis at the end of the most recent reporting period. Hedge funds and other institutional investors own 17.73% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Aemetis (AMTX) Upgraded to Hold at Zacks Investment Research” was first published by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://www.watchlistnews.com/aemetis-amtx-upgraded-to-hold-at-zacks-investment-research/1812317.html.

Aemetis Company Profile

Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.

Get a free copy of the Zacks research report on Aemetis (AMTX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.